Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06335823 · ClinicalTrials.gov registry record · NA

Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient Gynecology

A NA study, sponsored by University Hospitals Cleveland Medical Center.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT06335823: Completed NA study, sponsored by University Hospitals Cleveland Medical Center.

NCT06335823 is a NA study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06335823, a NA study, has completed, sponsored by University Hospitals Cleveland Medical Center.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

Pain with intrauterine device (IUD) insertion is very common and there are few options for patients to help reduce this pain. Transcutaneous electric nerve stimulators (TENS) are a non-invasive procedure that may help reduce the pain with IUD insertions. The investigators hope that the information gleaned from this study will result in pain control options for future patients who desire an IUD placement.

Primary Outcome

The VAS score is a score of 0-10 with 0 being no pain and 10 being the worse pain imaginable

Interventions

  • DEVICE Transcutaneous electrical nerve stimulation (TENS)
  • DEVICE Placebo Transcutaneous electrical nerve stimulation (TENS)

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-06-05
Est. Completion 2025-02-07
Phase NA

What the finished NCT06335823 record still lists

NCT06335823 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which Transcutaneous electrical nerve stimulation (TENS) is the first listed.

NCT06335823 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06335823 about?

NCT06335823 is a clinical study titled "Efficacy of Transcutaneous Electrical Nerve Stimulation (TENS) for Pain Reduction During Intrauterine Device (IUD) Insertion in Outpatient Gynecology". Pain with intrauterine device (IUD) insertion is very common and there are few options for patients to help reduce this pain. Transcutaneous electric nerve stimulators (TENS) are a non-invasive procedure that may help reduce the pain with IUD insertions. The investigators hope that the information g...

What is the current status of trial NCT06335823?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2024-06-05. Estimated completion is 2025-02-07.

What interventions are being tested in trial NCT06335823?

The interventions under investigation include: Transcutaneous electrical nerve stimulation (TENS) (DEVICE), Placebo Transcutaneous electrical nerve stimulation (TENS) (DEVICE).

Who is sponsoring clinical trial NCT06335823?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06335823's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06335823, the US trial registry maintained by the National Library of Medicine. NCT06335823 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.